Climate Change Data

BIOSYNEX

Climate Impact & Sustainability Data (2022-01 to 2022-06, 2023, 2023-01 to 2023-06, 2024-01 to 2024-06)

Reporting Period: 2022-01 to 2022-06

Environmental Metrics

Governance Achievements

  • Renewed the mandates of President and CEO Larry Abensur and Deputy CEO Thierry Paper for six years until 2028.
  • Renewed the mandate of Elie Fraenckel as administrator for six years until 2028.
  • Reduced the company's capital by canceling treasury stock, in compliance with Article L.22-10-65 of the French Commercial Code.

Climate Goals & Targets

Environmental Challenges

  • Decrease in Covid-19 related sales due to improved health situation and increased competition.
  • Price increases imposed by suppliers and logistics providers due to the situation in Ukraine.
Mitigation Strategies
  • Accelerated diversification strategy, resulting in a 27% increase in non-Covid-19 activity.
  • Taking measures to preserve margins in the face of supplier price increases.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2023

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

  • Significant decrease in Covid-19 product sales.
  • Financial covenants breach.
  • Liquidity risk.
  • Integration challenges of acquisitions.
  • Risks related to internationalization.
  • Risks related to the development and success of new products.
  • Risks related to healthcare systems.
  • Risks related to regulations and various legislations.
Mitigation Strategies
  • Diversification strategy.
  • Discussions with lenders for waivers and debt restructuring.
  • Seeking new external financing (equity/quasi-equity).
  • Rigorous selection process for acquisitions and detailed integration plans.
  • Legal and regulatory monitoring.
  • Focus on integrating acquisitions and building centers of excellence.
  • Aiming for profitability through growth, reduced costs, and operational efficiency.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2023-01 to 2023-06

Environmental Metrics

Climate Goals & Targets

Environmental Challenges

  • Significant decrease in COVID-19 sales (70% decrease compared to the first half of 2022).
  • Liquidity risk due to high debt and potential non-compliance with financial covenants.
  • Recall of microwavable hot water bottles due to fire and burn risks.
Mitigation Strategies
  • Continued implementation of a transformation plan, including diversification of the DIAGNOSTIC division and continued commercialization of prevention and family health products in the PHARMACIE division.
  • Negotiations with the banking pool to obtain a waiver for non-compliance with financial covenants.
  • Discontinuation of the sale of the recalled hot water bottles and a reevaluation of the risk associated with the recall.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Period: 2024-01 to 2024-06

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Established a CSR (Corporate Social Responsibility) committee.

Governance Achievements

  • Appointed Diane Bessin and Brigitte Geny as directors.
  • Created a CSR committee.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Liquidity risk due to high debt levels and potential non-compliance with financial covenants.
  • Integration of US activities which remain deficit.
  • Destruction of expired Covid-19 stocks.
Mitigation Strategies
  • Initiated discussions with lenders for debt restructuring (maturity extension, covenant flexibility).
  • Implemented cost reduction measures and synergy deployment, leading to a 10% reduction in workforce.
  • Rationalization of US industrial activities, including the planned closure of the PROCISEDX site in February 2025.
  • Restructuring of US commercial activities.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: IVDR certification for a biotherapy monitoring test.

Third-party Assurance: Deloitte & Associés (limited review)

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed